SEP 15, 2019 8:31 PM PDT

New Observations of a Cancer Transcriptase

WRITTEN BY: Amanda Mikyska

New research shows a transcriptase that helps time cell death varies in expression, and is unusually localized, in cancer cells.  The transcriptase, Telomerase Reverse Transcriptase (TERT), is responsible for maintaining and protecting the ends of the chromosome from degradation.  

Dreamstime

 

The life of a healthy cell is programmed to end when the telomerase inevitably begins to deteriorate.  In cancerous cells, TERT is overactive and extends the telomerase, even when the cell's overall health is declining.  The infinite extension means cell death is never signaled, giving cancer cells their immortal quality.  

Researchers from the University of Colorado Boulder and the BioFrontiers Institute used single-molecule RNA fluorescent in situ hybridization (sm-FISH) to examine TERT expression and localization in individual cancer cells.  For the first time, researchers were able to compare TERT expression in individual cells.  Expression was measured in cells with the same and different cancer types.  These nuanced observations of cancer-driving transcriptases are critical for developing gene-therapies.  

By visualizing individual cells, researchers are now able to see that TERT is expressed in varying amounts among cells in the same tumor.  Similarly, patterns of TERT expression are not consistent across all cancers.  The researchers looked at cells of ten different types of cancers and found that even though TERT is overactive in all of these, it is active at different levels.  Previous literature studied TERT expression by observing cells in a tumor as a whole, obscuring variation in expression.  

One other unexpected observation is that the TERT mRNA is found primarily in the nucleus, while mRNA is usually found in the cytoplasm where it is processed and made into protein.  The researchers even observed the odd localization of TERT in stem cells, showing that the localization is not due to the cancer.  It is still unknown why the TERT mRNA is localized in the nucleus, and the researchers plan to investigate this question further.  

TERT is a hopeful target for gene-therapies that could cure many types of cancer.  Research about TERT activity is important in determining if the protein could be useful in curing cancer.  

 

Sources:  Rowland et al., University of Colorado Boulder

 

About the Author
Bachelor's (BA/BS/Other)
Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
OCT 28, 2022
Coronavirus
The New GenElute™-E Viral RNA/DNA Kit
The New GenElute™-E Viral RNA/DNA Kit
Three Advantages: Reduction in plastic use Time savings Better results Nucleic acids play an essential role in the funct ...
NOV 01, 2022
Cardiology
Autoimmune Disorders Increase Cardiovascular Risk
Autoimmune Disorders Increase Cardiovascular Risk
People with autoimmune disorders are significantly more likely to develop heart disease compared to the general populati ...
NOV 17, 2022
Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Vitamin B3, also known as niacin, is a generic name for a group of biochemical compounds, including nicotinamide ribosid ...
NOV 18, 2022
Immunology
COVID-19 Can Reactivate Latent Viruses
COVID-19 Can Reactivate Latent Viruses
Viral infections can trigger other dormant, or latent viruses. For example, the herpesviruses HSV and CMV can be reactiv ...
DEC 08, 2022
Cancer
Could a Drug for Parkinson's Disease Reduce the Side Effects of Chemotherapy?
Could a Drug for Parkinson's Disease Reduce the Side Effects of Chemotherapy?
Chemotherapies, drugs used to fight cancer by killing tumor cells or preventing them from growing and dividing, remain s ...
DEC 11, 2022
Immunology
The First Drug That Can Delay Type 1 Diabetes Onset is Approved
The First Drug That Can Delay Type 1 Diabetes Onset is Approved
About 30,000 people are diagnosed with type 1 diabetes every year in the United States, and it's a common chronic diseas ...
Loading Comments...